American Marconi Wireless News

Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN

Admission of New Ordinary Shares and New ISIN

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress

Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed at providing comprehensive solutions for patients with obstructive sleep apnea (OSA) and associated oxidative stress. This collaboration combines Vivos Therapeutics' FDA-cleared oral medical devices for treating moderate to severe OSA in children and adults with Cellev8 Nutrition's proprietary gummy form of nutraceuticals featuring the powerful enzymatic antioxidant, SOD2, designed to mitigate oxidative stress in the body.

World’s largest Psychedelic Church to Close SF Site in Coming Weeks Pastor Cites Harassment from City Planning Department

Zide Door, the psychedelic church garnering national recognition for its devotion to the spiritual power of psilocybin mushrooms, will close its San Francisco location by the end of this year - the victim of a city planning department bent on expelling the institution, Pastor Dave Hodges said Tuesday.Church of Ambrosia, which opened Zide Door April 15, 2023, will continue to serve all 120,000 church members at its founding site in Oakland, he said. The Oakland church showcases an impressive mural and other significant psychedelic art.

Pharmacy Benefit Managers: Driving Cost Savings and Innovation in Healthcare

Real value in working with Canada Drugs Direct as a partner pharmacy that is able to serve as a PBM

Forward Water Technologies Corp Announces Completion of First Trials for the Production of Lithium Carbonate

Forward Water Technologies Corp. (TSXV:FWTC) ("Forward Water" or the "Company") in conjunction with CleanTech Lithium (CTL)(T2)(CTLHF) ("CTL") and Conductive Energy Inc. ("CE") have completed first trials for the production of lithium carbonate from brines sourced in Chile. CTL produced lithium brine eluate from their facilities in Chile and delivered these lithium rich brines to CE's operational site in Chicago, Illinois, USA. CE and FWTC then successfully processed the eluate brine to lithium carbonate using CE's chemical conversion technology and FWTC's proprietary iFOTM process for high strength brine concentration.

Brainy, 'normal guy': the suspect in US insurance CEO's slaying

The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.

Connected, brainy, athletic: the suspect in US insurance CEO's slaying

The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.

Suspect arrested after hunt for US insurance chief's killer

A 26-year-old man was arrested Monday over the targeted killing of a health insurance executive on the streets of New York, with police crediting a McDonald's employee in Pennsylvania who spotted a suspicious-looking customer.

French film director denies child actor abuse in landmark trial

A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 denied the charges Monday as his trial opened in Paris, five years after her allegations fired France's #MeToo movement.

Syria rebel leader discusses 'transfer of power' after Assad's fall

Syria's Islamist rebel leader on Monday began discussions on transferring power, a day after rebels dramatically unseated president Bashar al-Assad following decades of brutal rule.

Man questioned in case of murdered health exec

A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.

Man questioned in case of murdered health exec: US media

A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.

Beaten 'unconscious': police violence sparks outrage in Georgia

When Georgian protester Irakli Pipia started praying with a feeble voice, the policeman beating him drew closer to grasp what he was saying.

China probes Nvidia for 'violating' anti-monopoly law

China on Monday launched an investigation into US chip giant Nvidia for allegedly violating its anti-monopoly laws, a top government agency said, as the two countries race for global chipmaking dominance.

Despair grips Afghan women healthcare students facing ban

For Saja, studying nursing at a healthcare institute in Kabul was her last lifeline to make something of herself after women were banned from universities in Afghanistan two years ago.

French director accused of abusing star Haenel goes on trial

A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 was to go on trial in Paris on Monday, five years after her allegations fired France's #MeToo movement.

Evacuations underway as Philippine volcano erupts

A volcano erupted in the central Philippines on Monday, sending a huge ash column high into the sky as the government ordered the evacuation of surrounding villages.

Trauma and terror of Kenya's kidnapped protesters

The Kenyan parliament was ablaze, protesters running through the streets, police firing into the crowds. Among them was John, who believed the unrest could bring about meaningful political change.

Australian police seek three suspects in 'terrorist' synagogue blaze

Australian police said Monday they are hunting for three suspects over an arson attack on a Melbourne synagogue, designating it a terrorist act.

Australian police seek three suspects in synagogue blaze

Australian police said on Monday they are hunting for three suspects over an arson attack on a Melbourne synagogue, which has been designated as a terrorist act.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 09

Purchase of own shares

Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed

Hemogenyx Pharmaceuticals Successfully Completes the Site Initiation Visit of the First Clinical Site for Phase I Clinical Trial of HG-CT-1

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment

("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, has achieved key milestones in the development of BNT23001, its proprietary sublingual thin-film (OFD) formulation of Cladribine for the treatment of Multiple Sclerosis (MS). These achievements in 2024 lay the groundwork for clinical trials and regulatory submissions in 2025, reinforcing BioNxt's commitment to advancing patient-centric therapeutic solutions.

Bots Inc. Announces Initiation of Quarterly Cash Dividend Program

Bots Inc. (OTC PINK:BTZI), a leading innovator in blockchain technology and decentralized applications, is pleased to announce that its Board of Directors has approved the initiation of a quarterly cash dividend program. The first regular quarterly cash dividend will be paid at a rate of $0.00001 per share.

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed an orally active protease inhibitor with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2).

Theralase(R) Launches Three New Clinical Study Sites in USA

Associated Medical Professionals of NY, Urology of Indiana and Central Ohio Urology Group are the latest three US-based study sites for clinical research of Theralase®'s bladder cancer treatment

BloomZ Announces Strategic Business Alliance with Foom Co. Ltd. to Expand into the Webtoon Industry

a leading Japanese anime production, audio production, and voice actor management company, announced a strategic business alliance with Foom Co., Ltd. ("Foom"), a Tokyo-based company specializing in webtoon production, to expand its presence into the webtoon industry.

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Positive results in recent animal study strongly support first-ever human investigation for DehydraTECH-liraglutide

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of CTD

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia

Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today it has granted Theramex the exclusive commercialization rights to ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures, for Mexico, Canada, Israel, South Africa, and Russia. Theramex will also have the opportunity to commercialize ELADYNOS® in other agreed upon unpartnered regions. Abaloparatide is marketed in the U.S. by Radius under the tradename TYMLOS®.

Global Licensing Group Highlights Commitment to Sustainability Excellence

Sharing key contributors, data-driven insights ignite eco-conscious results across the platform's leading events.

RBGPF	0%	60.5	$
NGG	0.6%	58.853	$
RYCEF	-0.97%	7.2	$
CMSC	0.33%	23.939	$
BTI	-0.6%	36.025	$
GSK	0.77%	33.86	$
RELX	-0.04%	45.45	$
VOD	-0.48%	8.35	$
BP	0.35%	28.7	$
RIO	0.56%	58.97	$
BCC	0.09%	122.86	$
SCS	-0.34%	11.7	$
BCE	-2.25%	22.651	$
CMSD	-0.01%	23.557	$
JRI	0.04%	12.065	$
AZN	1.09%	66.07	$

American Marconi Wireless News - Boulevard (English)

Featured

Biden commutes almost all federal death sentences

France's new government to be announced Monday evening: Elysee

Last news